Pricing Log in Create free account

BioAge Labs, Inc. (BIOA) vs Siga Technologies Inc. (SIGA)

BioAge Labs, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. is the larger, with a market value of $254.3M against $213.4M — 1.2× the size. Siga Technologies Inc. has the higher net margin (−5.19% vs −1,253.6%) and the higher return on invested capital (−14.6% vs −21.8%). Across the 15 metrics below, Siga Technologies Inc. leads on 11 and BioAge Labs, Inc. on 4.

Valuation

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 29.58 3.97 2.08
P/B 0.73 1.29 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.52 n/m 12.22
EV/Sales (7.23) 4.74 2.87
Earnings yield (46.03%) (1.35%) (15.94%)
Free cash flow yield (101.34%) (9.63%) 0.00%

Profitability

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Gross margin 100.00% 54.35% 53.51%
Operating margin (1,401.81%) (20.76%) 0.00%
Net margin (1,253.60%) (5.19%) (2.45%)
Free cash flow margin (2,997.41%) (37.58%) 0.00%
Return on equity (34.56%) (1.49%) (0.80%)
Return on assets (32.05%) (1.36%) (1.67%)
Return on invested capital (21.75%) (14.59%) 0.00%

Growth

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (70.13%) 5.22%
EPS growth (last fiscal year) 66.21% (60.98%) 42.91%
Revenue growth, 5-year CAGR — (5.42%) 7.24%
Net income growth, 5-year CAGR — (16.20%) 0.00%

Health

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 15.51 21.72 2.41
Net debt to EBITDA 3.01 (6.39) 1.01

Dividend

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric BIOA SIGA Drug Manufacturers Specialty & Generic median
Market cap 254.27m 213.40m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack